Brief: Ocumension Therapeutics Says HY Loss And Total Comprehensive Expenses RMB 1.74 Bln
26/08/2020 11:44
Aug 26 (Reuters) - Ocumension Therapeutics 1477.HK :
* HY LOSS AND TOTAL COMPREHENSIVE EXPENSES RMB 1.74 BILLION
VERSUS
LOSS RMB 247.9 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS6s4kFz
Further company coverage: 1477.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocumension Therapeutics
See all newsBrief: Ocumension Therapeutics Says NMPA Accepts NDA For OT-301 (NCX 470, Bimatoprost Grenod)
Brief: Ocumension Therapeutics Says Dexamethasone Intraocular Suspension Application Accepted By NMPA
Brief: Ocumension Therapeutics Says HY Adjusted Net Loss Rmb57.5 Million
China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product sales
Ocumension jumps most in three months on China nod for new drug application